首页>
外国专利>
IN VITRO METHOD FOR DETECTING THYROID CANCER IN A PATIENT, IN VITRO METHOD FOR DIFFERENTIATING BETWEEN THYROID CANCER AND NORMAL THYROID TISSUE OR BENIGN THYROID LESIONS, USE OF A SERIES OF GENES, METHOD FOR OBTAINING DATA DETERMINING THE TREATMENT OF THYROID CANCER, LABORATORY KIT AND DEVICE FOR CLASSIFYING A BIOLOGICAL SAMPLE FROM THE THYROID GLAND AS MALIGNANT OR BENIGN
IN VITRO METHOD FOR DETECTING THYROID CANCER IN A PATIENT, IN VITRO METHOD FOR DIFFERENTIATING BETWEEN THYROID CANCER AND NORMAL THYROID TISSUE OR BENIGN THYROID LESIONS, USE OF A SERIES OF GENES, METHOD FOR OBTAINING DATA DETERMINING THE TREATMENT OF THYROID CANCER, LABORATORY KIT AND DEVICE FOR CLASSIFYING A BIOLOGICAL SAMPLE FROM THE THYROID GLAND AS MALIGNANT OR BENIGN
The present invention relates, in general, to an in vitro method for detecting thyroid cancer in a patient, and to an in vitro method for distinguishing thyroid cancer from benign lesions or normal thyroid tissue, on the basis of the evaluation of the expression of the series of genes CLDN10, HMGA2 e LAMB3, using a quantitative molecular detection technique. The invention further relates to other aspects associated with these methods, namely, the use of a series of genes, a method for obtaining data for determining the treatment of thyroid cancer, a laboratory kit and a device for classifying a biological sample from the thyroid gland as malignant or benign.
展开▼
机译：总的来说，本发明涉及用于在患者中检测甲状腺癌的体外方法，以及用于将甲状腺癌与良性病变或正常病变区分开的体外方法。使用定量分子检测技术，在评估一系列基因CLDN10，HMGA2 e LAMB3的表达的基础上，评估甲状腺组织。本发明还涉及与这些方法有关的其他方面，即，一系列基因的使用，用于确定甲状腺癌治疗的数据的获取方法，实验室试剂盒和用于对来自甲状腺的生物样品进行分类的装置。恶性或良性。
展开▼
